BACKGROUND: Myocardial recovery after ventricular assist devices (VAD) is rare but appears more common in nonischemic cardiomyopathies (NICM). We sought to evaluate left ventricular (LV) end diastolic diameter (LVEDD) for predicting recovery after VAD. METHODS AND RESULTS: NICM patients receiving long-term mechanical support between 1996 and 2008 were reviewed. Subjects were divided into 3 groups: mild, moderate, and severe dilation (Group A: LVEDD <6.0 cm [n = 22]; Group B: 6.0-7.0 cm [n = 32]; Group C: >7.0 cm [n = 48], respectively). Overall, recovery (successful explant without transplantation) occurred in 14 of 102 subjects (14%). Of these, 2 died and 2 required transplantation within 1 year. Recovery was more common in patients without LV dilation (Groups A/B/C = 32%/22%/0%, P < .001), as was sustained recovery (alive and transplant free 1 year after explant; A/B/C = 27%/10%/0%, P = .001). Of the recovery patients in Group A, 6/7 (86%) had sustained recovery versus 3/6 (50%) in Group B. CONCLUSIONS: Recovery occurred in 32% of NICM patients without significant LV dilation at time of VAD, the majority of whom experienced significant sustained recovery. Recovery was not evident in those with severe LV dilation. Routine echocardiography at the time of implant may assist in targeting patients for recovery after VAD. Copyright 2010 Elsevier Inc. All rights reserved.
BACKGROUND: Myocardial recovery after ventricular assist devices (VAD) is rare but appears more common in nonischemic cardiomyopathies (NICM). We sought to evaluate left ventricular (LV) end diastolic diameter (LVEDD) for predicting recovery after VAD. METHODS AND RESULTS: NICM patients receiving long-term mechanical support between 1996 and 2008 were reviewed. Subjects were divided into 3 groups: mild, moderate, and severe dilation (Group A: LVEDD <6.0 cm [n = 22]; Group B: 6.0-7.0 cm [n = 32]; Group C: >7.0 cm [n = 48], respectively). Overall, recovery (successful explant without transplantation) occurred in 14 of 102 subjects (14%). Of these, 2 died and 2 required transplantation within 1 year. Recovery was more common in patients without LV dilation (Groups A/B/C = 32%/22%/0%, P < .001), as was sustained recovery (alive and transplant free 1 year after explant; A/B/C = 27%/10%/0%, P = .001). Of the recovery patients in Group A, 6/7 (86%) had sustained recovery versus 3/6 (50%) in Group B. CONCLUSIONS: Recovery occurred in 32% of NICM patients without significant LV dilation at time of VAD, the majority of whom experienced significant sustained recovery. Recovery was not evident in those with severe LV dilation. Routine echocardiography at the time of implant may assist in targeting patients for recovery after VAD. Copyright 2010 Elsevier Inc. All rights reserved.
Authors: H Milting; B Bartling; H Schumann; A El-Banayosy; S Wlost; F Rüter; D Darmer; J Holtz; R Körfer; H R Zerkowski Journal: Thorac Cardiovasc Surg Date: 1999-02 Impact factor: 1.827
Authors: P M McCarthy; N O Smedira; R L Vargo; M Goormastic; R E Hobbs; R C Starling; J B Young Journal: J Thorac Cardiovasc Surg Date: 1998-04 Impact factor: 5.209
Authors: G Torre-Amione; S J Stetson; K A Youker; J B Durand; B Radovancevic; R M Delgado; O H Frazier; M L Entman; G P Noon Journal: Circulation Date: 1999-09-14 Impact factor: 29.690
Authors: Vinay Thohan; Sonny J Stetson; Sherif F Nagueh; Carlos Rivas-Gotz; Michael M Koerner; Javier A Lafuente; Matthias Loebe; George P Noon; Guillermo Torre-Amione Journal: J Heart Lung Transplant Date: 2005-05 Impact factor: 10.247
Authors: D J Goldstein; N Moazami; J A Seldomridge; H Laio; R C Ashton; Y Naka; D J Pinsky; M C Oz Journal: Ann Thorac Surg Date: 1997-04 Impact factor: 4.330
Authors: Khuram W Chaudhary; Eric I Rossman; Valentino Piacentino; Agnes Kenessey; Chris Weber; John P Gaughan; Kaie Ojamaa; Irwin Klein; Donald M Bers; Steven R Houser; Kenneth B Margulies Journal: J Am Coll Cardiol Date: 2004-08-18 Impact factor: 24.094
Authors: D M Mancini; A Beniaminovitz; H Levin; K Catanese; M Flannery; M DiTullio; S Savin; M E Cordisco; E Rose; M Oz Journal: Circulation Date: 1998-12-01 Impact factor: 29.690
Authors: Stavros G Drakos; Abdallah G Kfoury; Josef Stehlik; Craig H Selzman; Bruce B Reid; John V Terrovitis; John N Nanas; Dean Y Li Journal: Circulation Date: 2012-07-10 Impact factor: 29.690
Authors: Diego A Lara; Aamir Jeewa; Barbara A Elias; Elizabeth O McCullum; Susan W Denfield; William J Dreyer; Iki Adachi Journal: Tex Heart Inst J Date: 2017-02-01
Authors: Stavros G Drakos; Abdallah G Kfoury; Craig H Selzman; Divya Ratan Verma; John N Nanas; Dean Y Li; Josef Stehlik Journal: Curr Opin Cardiol Date: 2011-05 Impact factor: 2.161
Authors: Craig H Selzman; Jesse L Madden; Aaron H Healy; Stephen H McKellar; Antigone Koliopoulou; Josef Stehlik; Stavros G Drakos Journal: Ann Thorac Surg Date: 2014-11-14 Impact factor: 4.330
Authors: Christos P Kyriakopoulos; Chris J Kapelios; Elizabeth L Stauder; Iosif Taleb; Rana Hamouche; Konstantinos Sideris; Antigone G Koliopoulou; Michael J Bonios; Stavros G Drakos Journal: J Clin Med Date: 2022-06-20 Impact factor: 4.964
Authors: Stavros G Drakos; Omar Wever-Pinzon; Craig H Selzman; Edward M Gilbert; Rami Alharethi; Bruce B Reid; Abdulfattah Saidi; Nikolaos A Diakos; Sandi Stoker; Erin S Davis; Matthew Movsesian; Dean Y Li; Josef Stehlik; Abdallah G Kfoury Journal: J Am Coll Cardiol Date: 2013-03-14 Impact factor: 24.094